文献速递瓣膜病与结构性心脏病心律失常

Fontan术后青少年与成人的临床结局

Clinical Outcomes in Adolescents and Adults After the Fontan Procedure.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

该研究基于澳大利亚与新西兰Fontan登记处(ANZFR)前瞻性纳入的683例≥16岁成人幸存者,分析其生存率与并发症。30岁生存率为90%(95%CI:87%~93%),40岁为80%(95%CI:75%~87%),AP连接者30岁生存率显著更差(p=0.03);仅53%为NYHA I级,41%(95%CI:33%~51%)在40岁时无严重不良事件。

要点

  • Fontan成人30岁生存率90%,40岁降至80%,AP连接者预后更差。
  • 随访中20%出现新发心律失常,21%需外科再干预,7%发生血栓栓塞。
  • 40岁时仅41%无严重不良事件,多数患者存在病态并发症。

核心结论

  • Fontan成人病态并发症常见,过早死亡发生率较高,尤其是AP连接患者。

研究设计与样本

  • 分析ANZFR前瞻性纳入的683例≥16岁成人幸存者,死亡状态经国家死亡指数确认。

主要发现

  • 30岁生存率90%(95%CI:87%~93%),40岁80%(95%CI:75%~87%)。
  • AP连接患者30岁生存率显著更差(p=0.03)。
  • 末次随访仅53%为NYHA功能I级。
  • ≥16岁后136例(20%)出现至少1次新发心律失常,42例(6%)需永久起搏器,45例(7%)发生血栓栓塞,135例(21%)需外科再干预。
  • 40岁时仅41%(95%CI:33%~51%)无严重不良事件。

临床怎么用

  • 对Fontan成人应加强心律失常、血栓栓塞及心功能监测,并警惕再干预需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term outcomes of Fontan patients who survive to age ≥16 years have not been well characterized. The Australian and New Zealand Fontan Registry (ANZFR) provides a unique opportunity to understand survival and complication rates in Fontan patients who transition to adult congenital heart disease centers. OBJECTIVES: This study sought to describe the survival and complications of adult patients who have had a Fontan procedure. METHODS: The study analyzed outcomes in patients ≥16 years of age who were prospectively enrolled in the ANZFR. RESULTS: Data from all 683 adult survivors from the ANZFR were analyzed. Mortality status was confirmed from the National Death Index. There were 201 atriopulmonary (AP) connections and 482 total cavopulmonary connections (249 lateral tunnels and 233 extracardiac conduits). For these subjects, the survival rate at age 30 years was 90% (95% CI: 87% to 93%), and it was 80% (95% CI: 75% to 87%) at 40 years of age. Survival at age 30 years was significantly worse for the patients with AP connections (p = 0.03). At latest follow-up, only 53% of patients were in New York Heart Association functional class I. After the age of 16 years, 136 (20%) had experienced at least 1 new arrhythmia, 42 (6%) required a permanent pacemaker, 45 (7%) had a thromboembolic event, and 135 (21%) required a surgical reintervention. Only 41% (95% CI: 33% to 51%) of Fontan patients were free of serious adverse events at 40 years of age. CONCLUSIONS: This comprehensively followed cohort showed that a variety of morbid complications is common in Fontan adults, and that there is a substantial incidence of premature death, particularly in patients with AP connections.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Dennis M, Zannino D, du Plessis K, et al. Clinical Outcomes in Adolescents and Adults After the Fontan Procedure. J Am Coll Cardiol. 2018. PMID: 29495980. doi:10.1016/j.jacc.2017.12.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。